Tokyo, Oct. 28 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059547) titled 'A study to evaluate the safety of excessive consumption of blue rose extract powder' on Oct. 27.
Study Type:
Interventional
Study Design:
Basic Design - Single arm
Randomization - Non-randomized
Blinding - Open -no one is blinded
Control - Uncontrolled
Primary Sponsor:
Institute - KINJIRUSHI Co., LTD.
Condition:
Condition - Healthy Japanese
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To evaluate the safety of excessive consumption of blue rose extract powder.
Basic objectives2 - Safety
Intervention:
Interventions/Control_1 - Duration: 4weeks
Test product: Au...